col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


111 Ergebisse       Seite 1

 [1] 
MDPI AG: Pharmaceutics
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Apr―01 Expanded Spectrum and Increased Incidence of Adverse Events Linked to COVID-19 Genetic Vaccines: New Concepts on Prophylactic Immuno-Gene Therapy, Iatrogenic Orphan Disease, and Platform-Inherent Challenges Janos Szebeni
2 [GO] 2025―Mrz―31 A Polysorbate-Based Lipid Nanoparticle Vaccine Formulation Induces In Vivo Immune Response Against SARS-CoV-2 Aishwarya Saraswat, Alireza Nomani, Lin-Kin Yong, Jimmy Chun-Tien Kuo, Heather Brown, Muralikrishna Narayanareddygari, et al. (+8)
3 [GO] 2025―Mrz―10 In Vitro Development of Local Antiviral Formulations with Potent Virucidal Activity Against SARS-CoV-2 and Influenza Viruses Juthaporn Ponphaiboon, Wantanwa Krongrawa, Sontaya Limmatvapirat, Sukannika Tubtimsri, Akanitt Jittmittraphap, Pornsawan Leaungwutiwong, et al. (+4)
4 [GO] 2024―Okt―25 The Impact of COVID-19 on RNA Therapeutics: A Surge in Lipid Nanoparticles and Alternative Delivery Systems Nargish Parvin, Tapas K. Mandal, Sang-Woo Joo
5 [GO] 2024―Okt―01 Development of Targeted Drug Delivery System for the Treatment of SARS-CoV-2 Using Aptamer-Conjugated Gold Nanoparticles Junghun Park, Hyogu Han, Jun Ki Ahn
6 [GO] 2024―Sep―27 Multidrug Combinations against SARS-CoV-2 Using GS-441524 or Ivermectin with Molnupiravir and/or Nirmatrelvir in Reconstituted Human Nasal Airway Epithelia Denise Siegrist, Hulda R. Jonsdottir, Mendy Bouveret, Bernadett Boda, Samuel Constant, Olivier B. Engler
7 [GO] 2024―Sep―06 Astodrimer Sodium Nasal Spray versus Placebo in Non-Hospitalised Patients with COVID-19: A Randomised, Double-Blinded, Placebo-Controlled Trial Stephen Winchester, Alex Castellarnau, Kashif Jabbar, Meera Nadir, Kapila Ranasinghe, Xavier Masramon, et al. (+3)
8 [GO] 2024―Jul―18 Comparative Efficacy of Inhaled and Intravenous Corticosteroids in Managing COVID-19-Related Acute Respiratory Distress Syndrome Ahmed A. Abdelkader, Bshra A. Alsfouk, Asmaa Saleh, Mohamed E. A. Abdelrahim, Haitham Saeed
9 [GO] 2024―Jul―12 Analysis of Survival Modification by Furosemide Use in a Cohort of Hospitalized COVID-19 Patients with Severe or Critical Disease in Mexico: Due to Its Chemical Structure, Furosemide Is More than Just a Diuretic Janet Diaz-Martinez, Wayne Kotzker, Martha A. Mendoza-Hernandez, Rajdeep S. Gadh, Gustavo A. Hernandez-Fuentes, Andrew Bañuelos, et al. (+9)
10 [GO] 2024―Jul―09 In Silico and In Vitro Studies of Terpenes from the Fabaceae Family Using the Phenotypic Screening Model against the SARS-CoV-2 Virus Natália Ferreira de Sousa, Gabrielly Diniz Duarte, Carolina Borsoi Moraes, Cecília Gomes Barbosa, Holli-Joi Martin, Nail N. Muratov, et al. (+5)
11 [GO] 2024―Jul―03 Synthesis and Characterization of Thiolated Nanoparticles Based on Poly (Acrylic Acid) and Algal Cell Wall Biopolymers for the Delivery of the Receptor Binding Domain from SARS-CoV-2 Ileana García-Silva, Susan Farfán-Castro, Sergio Rosales-Mendoza, Gabriela Palestino
12 [GO] 2024―Jun―21 Layered Double Hydroxides (LDH) as Delivery Vehicles of a Chimeric Protein Carrying Epitopes from the Porcine Reproductive and Respiratory Syndrome Virus María José Alonso-Cerda, Mariano J. García-Soto, Arleth Miranda-López, René Segura-Velázquez, José Ivan Sánchez-Betancourt, Omar González-Ortega, Sergio Rosales-Mendoza
13 [GO] 2024―Jun―12 Evaluation of Novel Nasal Mucoadhesive Nanoformulations Containing Lipid-Soluble EGCG for Long COVID Treatment Nicolette Frank, Douglas Dickinson, Garrison Lovett, Yutao Liu, Hongfang Yu, Jingwen Cai, et al. (+3)
14 [GO] 2024―Jun―03 Inhibition of SARS-CoV-2-Induced NLRP3 Inflammasome-Mediated Lung Cell Inflammation by Triphala-Loaded Nanoparticle Targeting Spike Glycoprotein S1 Chuda Chittasupho, Sonthaya Umsumarng, Kamonwan Srisawad, Punnida Arjsri, Rungsinee Phongpradist, Weerasak Samee, et al. (+3)
15 [GO] 2024―Mai―02 Ligand- and Structure-Based Virtual Screening Identifies New Inhibitors of the Interaction of the SARS-CoV-2 Spike Protein with the ACE2 Host Receptor Timoteo Delgado-Maldonado, Alonzo González-González, Adriana Moreno-Rodríguez, Virgilio Bocanegra-García, Ana Verónica Martinez-Vazquez, Erick de Jesús de Luna-Santillana, et al. (+4)
16 [GO] 2024―Mrz―27 Antiviral Effect of Antimicrobial Peptoid TM9 and Murine Model of Respiratory Coronavirus Infection Maxim Lebedev, Aaron B. Benjamin, Sathish Kumar, Natalia Molchanova, Jennifer S. Lin, Kent J. Koster, et al. (+3)
17 [GO] 2024―Mrz―18 Effects of Combined Treatment with Sodium Dichloroacetate and Sodium Valproate on the Genes in Inflammation- and Immune-Related Pathways in T Lymphocytes from Patients with SARS-CoV-2 Infection with Pneumonia: Sex-Related Differences Donatas Stakišaitis, Linas Kapočius, Vacis Tatarūnas, Dovydas Gečys, Auksė Mickienė, Tomas Tamošuitis, et al. (+4)
18 [GO] 2024―Feb―14 Silver Nanoparticles In Situ Synthesized and Incorporated in Uniaxial and Core-Shell Electrospun Nanofibers to Inhibit Coronavirus Camila F. de Freitas, Paulo R. Souza, Gislaine S. Jacinto, Thais L. Braga, Yara S. Ricken, Gredson K. Souza, et al. (+5)
19 [GO] 2024―Feb―09 Population Pharmacokinetic Model of Linezolid and Probability of Target Attainment in Patients with COVID-19-Associated Acute Respiratory Distress Syndrome on Veno-Venous Extracorporeal Membrane Oxygenation-A Step toward Correct Dosing Dragana Milaković, Tijana Kovačević, Pedja Kovačević, Vedrana Barišić, Sanja Avram, Saša Dragić, et al. (+4)
20 [GO] 2024―Feb―02 The Design, Synthesis and Mechanism of Action of Paxlovid, a Protease Inhibitor Drug Combination for the Treatment of COVID-19 Miklós Bege, Anikó Borbás
21 [GO] 2024―Jan―29 Antiviral Action against SARS-CoV-2 of a Synthetic Peptide Based on a Novel Defensin Present in the Transcriptome of the Fire Salamander (Salamandra salamandra) Ana Luisa A. N. Barros, Vladimir C. Silva, Atvaldo F. Ribeiro-Junior, Miguel G. Cardoso, Samuel R. Costa, Carolina B. Moraes, et al. (+18)
22 [GO] 2024―Jan―25 Identification of Triazolopyrimidinyl Scaffold SARS-CoV-2 Papain-Like Protease (PLpro) Inhibitor Sebastjan Kralj, Marko Jukič, Miha Bahun, Luka Kranjc, Anja Kolarič, Milan Hodošček, et al. (+2)
23 [GO] 2023―Dez―19 Intracellular Degradation of SARS-CoV-2 N-Protein Caused by Modular Nanotransporters Containing Anti-N-Protein Monobody and a Sequence That Recruits the Keap1 E3 Ligase Yuri V. Khramtsov, Alexey V. Ulasov, Tatiana N. Lupanova, Tatiana A. Slastnikova, Andrey A. Rosenkranz, Egor S. Bunin, et al. (+2)
24 [GO] 2023―Dez―18 SARS-CoV-2 Fusion Peptide Conjugated to a Tetravalent Dendrimer Selectively Inhibits Viral Infection Carla Zannella, Annalisa Chianese, Alessandra Monti, Rosa Giugliano, Maria Vittoria Morone, Francesco Secci, et al. (+5)
25 [GO] 2023―Dez―12 Enhancing Immunogenicity of a Thermostable, Efficacious SARS-CoV-2 Vaccine Formulation through Oligomerization and Adjuvant Choice Mohammad Suhail Khan, Virginie Jakob, Randhir Singh, Raju S. Rajmani, Sahil Kumar, Céline Lemoine, et al. (+4)
26 [GO] 2023―Okt―25 Development and Evaluation of a Self-Nanoemulsifying Drug Delivery System for Sinapic Acid with Improved Antiviral Efficacy against SARS-CoV-2 Hani A. Alhadrami, Ahmed S.G. Srag El-Din, Hossam M. Hassan, Ahmed M. Sayed, Albaraa H. Alhadrami, Mostafa E. Rateb, Demiana M. Naguib
27 [GO] 2023―Aug―29 Spray-Dried Inhalable Microparticles Combining Remdesivir and Ebselen against SARS-CoV-2 Infection Tushar Saha, Shubhra Sinha, Rhodri Harfoot, Miguel E. Quiñones-Mateu, Shyamal C. Das
28 [GO] 2023―Aug―02 SARS-CoV-2 Papain-like Protease Responsive ZnO/Daclatasvir-Loaded Chitosan/Gelatin Nanofibers as Smart Antimicrobial Medical Textiles: In Silico, In Vitro and Cell Studies Mohamed Hamdi, Akram M. Elkashlan, Mohamed A. Hammad, Isra H. Ali
29 [GO] 2023―Jul―20 What We Learned about the Feasibility of Gene Electrotransfer for Vaccination on a Model of COVID-19 Vaccine Urska Kamensek, Maja Cemazar, Simona Kranjc Brezar, Tanja Jesenko, Spela Kos, Katarina Znidar, et al. (+7)
30 [GO] 2023―Jul―06 Montelukast and Telmisartan as Inhibitors of SARS-CoV-2 Omicron Variant Nirmitee Mulgaonkar, Haoqi Wang, Junrui Zhang, Christopher M. Roundy, Wendy Tang, Sankar Prasad Chaki, et al. (+3)
31 [GO] 2023―Mai―31 Antiviral Peptides Delivered by Chitosan-Based Nanoparticles to Neutralize SARS-CoV-2 and HCoV-OC43 Avinash Mali, Gianluigi Franci, Carla Zannella, Annalisa Chianese, Shubaash Anthiya, Ana M. López-Estévez, et al. (+5)
32 [GO] 2023―Mai―23 Ginkgo Biloba and Long COVID: In Vivo and In Vitro Models for the Evaluation of Nanotherapeutic Efficacy Thelma Akanchise, Angelina Angelova
33 [GO] 2023―Mai―05 The Screening of Broadly Neutralizing Antibodies Targeting the SARS-CoV-2 Spike Protein by mRNA Immunization in Mice Zhiyin An, Yu Zhang, Xiang Yu, Jia Xia, Yanan Yin, Guoming Li, et al. (+3)
34 [GO] 2023―Apr―28 Microneedles: An Emerging Vaccine Delivery Tool and a Prospective Solution to the Challenges of SARS-CoV-2 Mass Vaccination Ya-Xiu Feng, Huan Hu, Yu-Yuen Wong, Xi Yao, Ming-Liang He
35 [GO] 2023―Mrz―22 An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro Davide D’Angelo, Eride Quarta, Stefania Glieca, Giada Varacca, Lisa Flammini, Simona Bertoni, et al. (+10)
36 [GO] 2023―Mrz―17 Plant-Derived Extracellular Vesicles as a Delivery Platform for RNA-Based Vaccine: Feasibility Study of an Oral and Intranasal SARS-CoV-2 Vaccine Margherita A. C. Pomatto, Chiara Gai, Federica Negro, Lucia Massari, Maria Chiara Deregibus, Cristina Grange, et al. (+2)
37 [GO] 2023―Mrz―13 Evaluation of In Vitro and In Vivo Antiviral Activities of Vitamin D for SARS-CoV-2 and Variants Chee-Keng Mok, Yan Ling Ng, Bintou Ahmadou Ahidjo, Zhen Qin Aw, Huixin Chen, Yi Hao Wong, et al. (+11)
38 [GO] 2023―Mrz―10 An Adjuvanted Inactivated SARS-CoV-2 Microparticulate Vaccine Delivered Using Microneedles Induces a Robust Immune Response in Vaccinated Mice Sharon Vijayanand, Smital Patil, Ipshita Menon, Keegan Braz Gomes, Akanksha Kale, Priyal Bagwe, et al. (+3)
39 [GO] 2023―Mrz―03 CuMV VLPs Containing the RBM from SARS-CoV-2 Spike Protein Drive Dendritic Cell Activation and Th1 Polarization Ana Isabel Sebastião, Daniela Mateus, Mylène A. Carrascal, Cátia Sousa, Luísa Cortes, Martin F. Bachmann, et al. (+4)
40 [GO] 2023―Feb―16 Efficacy and Safety of Inhaled Ethanol in Early-Stage SARS-CoV-2 Infection in Older Adults: A Phase II Randomized Clinical Trial Ana Castro-Balado, Ignacio Novo-Veleiro, Néstor Vázquez-Agra, Gema Barbeito-Castiñeiras, Ana Estany-Gestal, Rocío Trastoy-Pena, et al. (+9)
41 [GO] 2023―Feb―15 Effects of Tocilizumab on Inflammation and Iron Metabolism in Critically Ill Patients with COVID-19 Robert Szabo, Cristina Petrișor, Constantin Bodolea, Vlad Dobre, Sebastian Tranca, Simona Clichici, et al. (+3)
42 [GO] 2023―Jan―30 Aspects of Nanotechnology for COVID-19 Vaccine Development and Its Delivery Applications Pranav Kumar Prabhakar, Navneet Khurana, Manish Vyas, Vikas Sharma, Gaber El-Saber Batiha, Harpreet Kaur, et al. (+5)
43 [GO] 2023―Jan―30 Effects of Dimerization, Dendrimerization, and Chirality in p-BthTX-I Peptide Analogs on the Antibacterial Activity and Enzymatic Inhibition of the SARS-CoV-2 PLpro Protein Natália Vitória Bitencourt, Gabriela Marinho Righetto, Ilana Lopes Baratella Cunha Camargo, Mariana Ortiz de Godoy, Rafael Victorio Carvalho Guido, Glaucius Oliva, et al. (+2)
44 [GO] 2023―Jan―20 Saponins: Research Progress and Their Potential Role in the Post-COVID-19 Pandemic Era Daniel Mieres-Castro, Freddy Mora-Poblete
45 [GO] 2023―Jan―19 Correction: Lee et al. The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b. Pharmaceutics 2022, 14, 1511 Yue-Zhi Lee, Hsing-Yu Hsu, Cheng-Wei Yang, Yi-Ling Lin, Sui-Yuan Chang, Ruey-Bing Yang, et al. (+8)
46 [GO] 2022―Dez―29 Synthesis of Novel 1,3,4-Oxadiazole-Derived α-Aminophosphonates/α-Aminophosphonic Acids and Evaluation of Their In Vitro Antiviral Activity against the Avian Coronavirus Infectious Bronchitis Virus Shaima Hkiri, Marwa Mekni-Toujani, Elvan Üstün, Karim Hosni, Abdeljelil Ghram, Soufiane Touil, et al. (+2)
47 [GO] 2022―Dez―19 Effects of Mangiferin on LPS-Induced Inflammation and SARS-CoV-2 Viral Adsorption in Human Lung Cells Mariarita Spampinato, Giuseppe Carota, Giuseppe Sferrazzo, Virginia Fuochi, Alfio Distefano, Simone Ronsisvalle, et al. (+7)
48 [GO] 2022―Nov―22 Biologic Functions of Hydroxychloroquine in Disease: From COVID-19 to Cancer Britney Niemann, Amanda Puleo, Conley Stout, Justin Markel, Brian A. Boone
49 [GO] 2022―Nov―22 Antibacterial and Antiviral Effects of Ag, Cu and Zn Metals, Respective Nanoparticles and Filter Materials Thereof against Coronavirus SARS-CoV-2 and Influenza A Virus Anna-Liisa Kubo, Kai Rausalu, Natalja Savest, Eva Žusinaite, Grigory Vasiliev, Mihkel Viirsalu, et al. (+4)
50 [GO] 2022―Nov―22 Formulation of SARS-CoV-2 Spike Protein with CpG Oligodeoxynucleotides and Squalene Nanoparticles Modulates Immunological Aspects Following Intranasal Delivery Hui-Min Ho, Chiung-Yi Huang, Chung-Hsiang Yang, Shih-Jen Liu, Hsin-Wei Chen, Guann-Yi Yu, et al. (+3)
51 [GO] 2022―Nov―18 Early Negativization of SARS-CoV-2 Infection by Nasal Spray of Seawater plus Additives: The RENAISSANCE Open-Label Controlled Clinical Trial Luca Cegolon, Giuseppe Mastrangelo, Enzo Emanuelli, Riccardo Camerotto, Giacomo Spinato, Daniele Frezza
52 [GO] 2022―Nov―07 Current Treatments for COVID-19: Application of Supercritical Fluids in the Manufacturing of Oral and Pulmonary Formulations Helga K. Ruiz, Dolores R. Serrano, Lourdes Calvo, Albertina Cabañas
53 [GO] 2022―Nov―03 Potent Virucidal Activity In Vitro of Photodynamic Therapy with Hypericum Extract as Photosensitizer and White Light against Human Coronavirus HCoV-229E Beatriz Praena, Marta Mascaraque, Sabina Andreu, Raquel Bello-Morales, Edgar Abarca-Lachen, Valentina Rapozzi, et al. (+4)
54 [GO] 2022―Okt―24 Optimization of In Vivo Electroporation Conditions and Delivery of DNA Vaccine Encoding SARS-CoV-2 RBD Using the Determined Protocol Denis Nikolaevich Kisakov, Lyubov Alexandrovna Kisakova, Maria Borisovna Borgoyakova, Ekaterina Vladimirovna Starostina, Oleg Svyatoslavovich Taranov, Elena Konstantinovna Ivleva, et al. (+9)
55 [GO] 2022―Okt―10 Lactoferrin Binding to SARS-CoV-2 Spike Glycoprotein Blocks Pseudoviral Entry and Relieves Iron Protein Dysregulation in Several In Vitro Models Antimo Cutone, Luigi Rosa, Maria Carmela Bonaccorsi di Patti, Federico Iacovelli, Maria Pia Conte, Giusi Ianiro, et al. (+6)
56 [GO] 2022―Sep―28 Structurally Modified Bioactive Peptide Inhibits SARS-CoV-2 Lentiviral Particles Expression Khushwant S. Bhullar, Manal A. Nael, Khaled M. Elokely, Steven J. Drews, Jianping Wu
57 [GO] 2022―Sep―28 Pharmacometric Modeling of the Impact of Azelastine Nasal Spray on SARS-CoV-2 Viral Load and Related Symptoms in COVID-19 Patients Christiane Dings, Peter Meiser, Frank Holzer, Michael Flegel, Dominik Selzer, Eszter Nagy, et al. (+3)
58 [GO] 2022―Sep―26 Sustained Delivery of a Monoclonal Antibody against SARS-CoV-2 by Microencapsulated Cells: A Proof-of-Concept Study Assem Ashimova, Askhat Myngbay, Sergey Yegorov, Baurzhan Negmetzhanov, Irina Kadyrova, Angelina Yershova, et al. (+3)
59 [GO] 2022―Sep―21 2D NMR Analysis as a Sensitive Tool for Evaluating the Higher-Order Structural Integrity of Monoclonal Antibody against COVID-19 Francesca Cantini, Emanuele Andreano, Ida Paciello, Veronica Ghini, Francesco Berti, Rino Rappuoli, Lucia Banci
60 [GO] 2022―Sep―08 The Impact of Angiotensin-Converting Enzyme-2/Angiotensin 1-7 Axis in Establishing Severe COVID-19 Consequences Minela Aida Maranduca, Daniela Maria Tanase, Cristian Tudor Cozma, Nicoleta Dima, Andreea Clim, Alin Constantin Pinzariu, et al. (+2)
61 [GO] 2022―Sep―07 Reply to Zandi, M.; Soltani, S. Comment on “Alfassam et al. Development of a Colorimetric Tool for SARS-CoV-2 and Other Respiratory Viruses Detection Using Sialic Acid Fabricated Gold Nanoparticles. Pharmaceutics 2021, 13, 502” Haya A. Alfassam, Majed S. Nassar, Manal M. Almusaynid, Bashayer A. Khalifah, Abdullah S. Alshahrani, Fahad A. Almughem, et al. (+8)
62 [GO] 2022―Sep―07 Comment on Alfassam et al. Development of a Colorimetric Tool for SARS-CoV-2 and Other Respiratory Viruses Detection Using Sialic Acid Fabricated Gold Nanoparticles. Pharmaceutics 2021, 13, 502 Milad Zandi, Saber Soltani
63 [GO] 2022―Aug―31 Drug-Disease Severity and Target-Disease Severity Interaction Networks in COVID-19 Patients Verena Schöning, Felix Hammann
64 [GO] 2022―Aug―01 Relationship between Pharmacokinetic/Pharmacodynamic Target Attainment and Microbiological Outcome in Critically Ill COVID-19 Patients with Documented Gram-Negative Superinfections Treated with TDM-Guided Continuous-Infusion Meropenem Maria Sanz Codina, Milo Gatti, Carla Troisi, Giacomo Fornaro, Zeno Pasquini, Filippo Trapani, et al. (+4)
65 [GO] 2022―Jul―22 The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b Yue-Zhi Lee, Hsing-Yu Hsu, Cheng-Wei Yang, Yi-Ling Lin, Sui-Yuan Chang, Ruey-Bing Yang, et al. (+8)
66 [GO] 2022―Jul―13 Using Dual Toll-like Receptor Agonism to Drive Th1-Biased Response in a Squalene- and α-Tocopherol-Containing Emulsion for a More Effective SARS-CoV-2 Vaccine Kristopher K. Short, Stephanie K. Lathrop, Clara J. Davison, Haley A. Partlow, Johnathan A. Kaiser, Rebekah D. Tee, et al. (+3)
67 [GO] 2022―Jul―07 Translating a Thin-Film Rehydration Method to Microfluidics for the Preparation of a SARS-CoV-2 DNA Vaccine: When Manufacturing Method Matters Allegra Peletta, Eakachai Prompetchara, Kittipan Tharakhet, Papatsara Kaewpang, Supranee Buranapraditkun, Nongnaphat Yostrerat, et al. (+8)
68 [GO] 2022―Jul―01 Celecoxib Microparticles for Inhalation in COVID-19-Related Acute Respiratory Distress Syndrome Monica-Carolina Villa-Hermosilla, Sofia Negro, Emilia Barcia, Carolina Hurtado, Consuelo Montejo, Mario Alonso, Ana Fernandez-Carballido
69 [GO] 2022―Mai―30 Post-COVID Syndrome: The Research Progress in the Treatment of Pulmonary sequelae after COVID-19 Infection Valentina Ruggiero, Rita P. Aquino, Pasquale Del Gaudio, Pietro Campiglia, Paola Russo
70 [GO] 2022―Mai―21 Development of an LNP-Encapsulated mRNA-RBD Vaccine against SARS-CoV-2 and Its Variants Cong Liu, Nino Rcheulishvili, Zhigao Shen, Dimitri Papukashvili, Fengfei Xie, Ziqian Wang, et al. (+3)
71 [GO] 2022―Mai―17 Potential of Microneedle Systems for COVID-19 Vaccination: Current Trends and Challenges Jasmin Hassan, Charlotte Haigh, Tanvir Ahmed, Md Jasim Uddin, Diganta B. Das
72 [GO] 2022―Mai―10 Convalescent Plasma Therapy, Therapeutic Formulations of Repurposed Drugs in 20th Century Epidemics against COVID-19: A Systematic Review Diego Fernández-Lázaro, Carlos Domínguez Ortega, Nerea Sánchez-Serrano, Fahd Beddar Chaib, David Jerves Donoso, Elena Jiménez-Callejo, Saray Rodríguez-García
73 [GO] 2022―Apr―19 Enhanced In Vitro Antiviral Activity of Hydroxychloroquine Ionic Liquids against SARS-CoV-2 Francisco Faísca, Vanessa Correia, Željko Petrovski, Luís C. Branco, Helena Rebelo-de-Andrade, Miguel M. Santos
74 [GO] 2022―Apr―14 Insect Cells for High-Yield Production of SARS-CoV-2 Spike Protein: Building a Virosome-Based COVID-19 Vaccine Candidate Bárbara Fernandes, Rute Castro, Farien Bhoelan, Denzel Bemelman, Ricardo A. Gomes, Júlia Costa, et al. (+6)
75 [GO] 2022―Apr―14 Peptide-Based Vaccine against SARS-CoV-2: Peptide Antigen Discovery and Screening of Adjuvant Systems Ahmed O. Shalash, Armira Azuar, Harrison Y. R. Madge, Naphak Modhiran, Alberto A. Amarilla, Benjamin Liang, et al. (+7)
76 [GO] 2022―Mrz―14 Safety of Tocilizumab in COVID-19 Patients and Benefit of Single-Dose: The Largest Retrospective Observational Study Ayman M. Al-Qaaneh, Fuad H. Al-Ghamdi, Sayed AbdulAzeez, J. Francis Borgio
77 [GO] 2022―Mrz―07 COVID-19 Drug Repurposing: A Network-Based Framework for Exploring Biomedical Literature and Clinical Trials for Possible Treatments Ahmed Abdeen Hamed, Tamer E. Fandy, Karolina L. Tkaczuk, Karin Verspoor, Byung Suk Lee
78 [GO] 2022―Mrz―01 Therapeutic Treatment Plan Optimization during the COVID-19 Pandemic: A Comprehensive Physicochemical Compatibility Study of Intensive Care Units Selected Drugs Maria Gloria Tarantini, Stéphanie Ramos, Philippe-Henri Secrétan, Laura Guichard, Lamia Hassani, Agnès Bellanger, et al. (+4)
79 [GO] 2022―Feb―28 Advances in the Prophylaxis of Respiratory Infections by the Nasal and the Oromucosal Route: Relevance to the Fight with the SARS-CoV-2 Pandemic Nadezhda Ivanova, Yoana Sotirova, Georgi Gavrailov, Krastena Nikolova, Velichka Andonova
80 [GO] 2022―Feb―09 Anticoronaviral Activity of the Natural Phloroglucinols, Dryocrassin ABBA and Filixic Acid ABA from the Rhizome of Dryopteris crassirhizoma by Targeting the Main Protease of SARS-CoV-2 Young-Hee Jin, Sangeun Jeon, Jihye Lee, Seungtaek Kim, Min Seong Jang, Chul Min Park, et al. (+3)
81 [GO] 2022―Jan―28 Inhibition of Escherichia Virus MS2, Surrogate of SARS-CoV-2, via Essential Oils-Loaded Electrospun Fibrous Mats: Increasing the Multifunctionality of Antivirus Protection Masks Joana M. Domingues, Marta O. Teixeira, Marta A. Teixeira, David Freitas, Samira F. da Silva, Shafagh D. Tohidi, et al. (+6)
82 [GO] 2022―Jan―10 In Silico Evaluation of Binding of 2-Deoxy-D-Glucose with Mpro of nCoV to Combat COVID-19 Anirudh Pratap Singh Raman, Kamlesh Kumari, Pallavi Jain, Vijay Kumar Vishvakarma, Ajay Kumar, Neha Kaushik, et al. (+3)
83 [GO] 2021―Dez―09 Antiviral Activity of the Rhamnolipids Mixture from the Antarctic Bacterium Pseudomonas gessardii M15 against Herpes Simplex Viruses and Coronaviruses Rosa Giugliano, Carmine Buonocore, Carla Zannella, Annalisa Chianese, Fortunato Palma Esposito, Pietro Tedesco, et al. (+4)
84 [GO] 2021―Nov―03 Broad Spectrum Antiviral Properties of Cardiotonic Steroids Used as Potential Therapeutics for Emerging Coronavirus Infections Young-Hee Jin, Sangeun Jeon, Jihye Lee, Seungtaek Kim, Min Seong Jang, Chul Min Park, et al. (+3)
85 [GO] 2021―Okt―25 Early Effects of Low Molecular Weight Heparin Therapy with Soft-Mist Inhaler for COVID-19-Induced Hypoxemia: A Phase IIb Trial Mustafa Erelel, Mert Kaskal, Ozlem Akbal-Dagistan, Halim Issever, Ahmet Serhan Dagistanli, Hilal Balkanci, et al. (+12)
86 [GO] 2021―Okt―22 A Comprehensive Review about the Molecular Structure of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Insights into Natural Products against COVID-19 Essa M. Saied, Yousra A. El-Maradny, Alaa A. Osman, Amira M. G. Darwish, Hebatallah H. Abo Nahas, Gniewko Niedbała, et al. (+4)
87 [GO] 2021―Okt―12 Activation of Tenofovir Alafenamide and Sofosbuvir in the Human Lung and Its Implications in the Development of Nucleoside/Nucleotide Prodrugs for Treating SARS-CoV-2 Pulmonary Infection Jiapeng Li, Shuhan Liu, Jian Shi, Hao-Jie Zhu
88 [GO] 2021―Okt―09 Can the Nasal Cavity Help Tackle COVID-19? Bissera Pilicheva, Radka Boyuklieva
89 [GO] 2021―Sep―29 Evaluation of Aerosol Drug Delivery Options during Adult Mechanical Ventilation in the COVID-19 Era Piers J. Naughton, Mary Joyce, Marc Mac Giolla Eain, Andrew O’Sullivan, Ronan MacLoughlin
90 [GO] 2021―Sep―22 Exploring Drugs and Vaccines Associated with Altered Risks and Severity of COVID-19: A UK Biobank Cohort Study of All ATC Level-4 Drug Categories Reveals Repositioning Opportunities Yong Xiang, Kenneth Chi-Yin Wong, Hon-Cheong So
91 [GO] 2021―Sep―22 Functionalized Dendrimer Platforms as a New Forefront Arsenal Targeting SARS-CoV-2: An Opportunity Serge Mignani, Xiangyang Shi, Andrii Karpus, Giovanni Lentini, Jean-Pierre Majoral
92 [GO] 2021―Sep―18 Mesenchymal Stromal Cells: Potential Option for COVID-19 Treatment Dragan Primorac, Martin Čemerin, Vid Matišić, Vilim Molnar, Marko Strbad, Lenart Girandon, et al. (+4)
93 [GO] 2021―Sep―06 Combination Therapy with Fluoxetine and the Nucleoside Analog GS-441524 Exerts Synergistic Antiviral Effects against Different SARS-CoV-2 Variants In Vitro Linda Brunotte, Shuyu Zheng, Angeles Mecate-Zambrano, Jing Tang, Stephan Ludwig, Ursula Rescher, Sebastian Schloer
94 [GO] 2021―Aug―23 Model-Informed Repurposing of Medicines for SARS-CoV-2: Extrapolation of Antiviral Activity and Dose Rationale for Paediatric Patients Federico Romano, Salvatore D’Agate, Oscar Della Pasqua
95 [GO] 2021―Aug―16 Nebulised Isotonic Hydroxychloroquine Aerosols for Potential Treatment of COVID-19 Waiting Tai, Michael Yee Tak Chow, Rachel Yoon Kyung Chang, Patricia Tang, Igor Gonda, Robert B. MacArthur, et al. (+2)
96 [GO] 2021―Aug―02 Mathematical Modeling of Remdesivir to Treat COVID-19: Can Dosing Be Optimized? Jessica M. Conway, Pia Abel zur Wiesch
97 [GO] 2021―Jul―14 Inhalation Delivery for the Treatment and Prevention of COVID-19 Infection Basanth Babu Eedara, Wafaa Alabsi, David Encinas-Basurto, Robin Polt, Julie G. Ledford, Heidi M. Mansour
98 [GO] 2021―Jul―07 Pre-Drawn Syringes of Comirnaty for an Efficient COVID-19 Mass Vaccination: Demonstration of Stability Francesca Selmin, Umberto M. Musazzi, Silvia Franzè, Edoardo Scarpa, Loris Rizzello, Patrizia Procacci, Paola Minghetti
99 [GO] 2021―Mai―31 A Review of Repurposed Cancer Drugs in Clinical Trials for Potential Treatment of COVID-19 Bárbara Costa, Nuno Vale
100 [GO] 2021―Mai―27 Biomedical Text Link Prediction for Drug Discovery: A Case Study with COVID-19 Kevin McCoy, Sateesh Gudapati, Lawrence He, Elaina Horlander, David Kartchner, Soham Kulkarni, et al. (+7)
101 [GO] 2021―Mai―24 Lipophilicity, Pharmacokinetic Properties, and Molecular Docking Study on SARS-CoV-2 Target for Betulin Triazole Derivatives with Attached 1,4-Quinone Monika Kadela-Tomanek, Maria Jastrzębska, Krzysztof Marciniec, Elwira Chrobak, Ewa Bębenek, Stanisław Boryczka
102 [GO] 2021―Apr―14 Drug Repurposing for COVID-19 Treatment by Integrating Network Pharmacology and Transcriptomics Dan-Yang Liu, Jia-Chen Liu, Shuang Liang, Xiang-He Meng, Jonathan Greenbaum, Hong-Mei Xiao, et al. (+2)
103 [GO] 2021―Apr―07 Development of a Colorimetric Tool for SARS-CoV-2 and Other Respiratory Viruses Detection Using Sialic Acid Fabricated Gold Nanoparticles Haya A. Alfassam, Majed S. Nassar, Manal M. Almusaynid, Bashayer A. Khalifah, Abdullah S. Alshahrani, Fahad A. Almughem, et al. (+8)
104 [GO] 2021―Apr―05 Tackling Immune Pathogenesis of COVID-19 through Molecular Pharmaceutics Matteo Puccetti, Claudio Costantini, Maurizio Ricci, Stefano Giovagnoli
105 [GO] 2021―Apr―02 A COVID-19 Drug Repurposing Strategy through Quantitative Homological Similarities Using a Topological Data Analysis-Based Framework Raul Pérez-Moraga, Jaume Forés-Martos, Beatriz Suay-García, Jean-Louis Duval, Antonio Falcó, Joan Climent
106 [GO] 2021―Mrz―08 Development and Characterization of Inhaled Ethanol as a Novel Pharmacological Strategy Currently Evaluated in a Phase II Clinical Trial for Early-Stage SARS-CoV-2 Infection Ana Castro-Balado, Cristina Mondelo-García, Letricia Barbosa-Pereira, Iria Varela-Rey, Ignacio Novo-Veleiro, Néstor Vázquez-Agra, et al. (+24)
107 [GO] 2021―Feb―26 Drug Repurposing in the COVID-19 Era: Insights from Case Studies Showing Pharmaceutical Peculiarities Milo Gatti, Fabrizio De De Ponti
108 [GO] 2021―Feb―26 Repurposing of Sitagliptin- Melittin Optimized Nanoformula against SARS-CoV-2: Antiviral Screening and Molecular Docking Studies Mohammed W. Al-Rabia, Nabil A. Alhakamy, Osama A. A. Ahmed, Khalid Eljaaly, Ahmed L. Aloafi, Ahmed Mostafa, et al. (+5)
109 [GO] 2020―Dez―22 Nuclear Medicine in Times of COVID-19: How Radiopharmaceuticals Could Help to Fight the Current and Future Pandemics Felix Neumaier, Boris D. Zlatopolskiy, Bernd Neumaier
110 [GO] 2020―Okt―05 COVID-19: Current Developments and Further Opportunities in Drug Delivery and Therapeutics Saman Zafar, Muhammad Sohail Arshad, Sameen Fatima, Amna Ali, Aliyah Zaman, Elshaimaa Sayed, et al. (+2)
111 [GO] 2020―Mai―11 MERS-CoV Spike Protein Vaccine and Inactivated Influenza Vaccine Formulated with Single Strand RNA Adjuvant Induce T-Cell Activation through Intranasal Immunization in Mice Hye-Jung Kim, Hye Won Kwak, Kyung Won Kang, Yoo-Jin Bang, Yu-Sun Lee, Hyeong-Jun Park, et al. (+5)
 [1] 

111 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.007 sec